New heart valve device offers hope for High-Risk patients

NCT ID NCT07501234

Recruiting now Disease control Sponsor: Mitrassist Lifesciences Limited Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This early study is testing a new device called the MitraFix system for adults with a severe leaky heart valve who are at high risk for traditional open-heart surgery. The device is delivered through a tube in the leg to try to fix the leaky valve. The main goals are to see if the procedure is safe, if the device can be placed correctly, and if it helps reduce the leak and improve patients' daily life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION (MR) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITING

Beijing, Beijing Municipality, 100037, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

MITRAL REGURGITATION (MR)